Drug Transport And Resistance Mechanisms
113 researchers across 9 institutions
Researchers in this area investigate how drugs move within the body and how cells or organisms develop resistance to them. This includes studying the molecular mechanisms that govern drug absorption, distribution, metabolism, and excretion, as well as identifying cellular processes that enable pathogens or cancer cells to evade therapeutic effects. Investigations employ a range of techniques, from in vitro assays and cell culture models to in vivo studies in animal models, to understand drug targets, efflux pumps, enzyme activity, and genetic mutations contributing to resistance. The work also explores strategies to overcome resistance, such as combination therapies and novel drug delivery systems.
This research holds significant relevance for Arkansas's public health and its growing biotechnology and pharmaceutical sectors. Understanding drug transport and resistance is crucial for developing more effective treatments for prevalent diseases within the state, including infectious diseases and cancer. Furthermore, this work supports the development of new therapeutic agents and diagnostic tools, potentially fostering innovation and economic growth in Arkansas's life sciences industry. Insights gained can also inform public health policies related to antimicrobial stewardship and personalized medicine.
This field draws upon expertise in pharmacology, molecular biology, biochemistry, and toxicology. The research is conducted across multiple Arkansas institutions, fostering collaboration and a comprehensive approach to addressing complex challenges in drug efficacy and resistance. Connections are evident with studies on pharmacological effects, cancer biology, microbial infections, and host-pathogen interactions.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Fenghuang Zhan | UAMS | 68 | 19,565 | Faculty | Grant PI High Impact |
| Peter Anthony Crooks | UAMS | 57 | 15,023 | ARA High Impact | |
| Timothy C. Chambers | UAMS | 35 | 4,732 | High Impact | |
| Wei Yang | University of Arkansas | 29 | 2,420 | Postdoctoral | |
| Gary Barone | UAMS | 28 | 4,690 | ||
| Donald G. Catanzaro | University of Arkansas | 23 | 2,104 | Faculty | High Impact |
| Darin E. Jones | UAMS | 22 | 1,163 | Faculty | High Impact |
| En Huang | UAMS | 21 | 1,042 | Faculty | Grant PI |
| Bijay K. Khajanchi | NCTR | 21 | 1,265 | High Impact | |
| César Sánchez | UAMS | 20 | 2,481 | Faculty | High Impact |
| Manit N. Munshi | UAMS | 20 | 1,508 | ||
| David F. Gilmore | Arkansas State University | 19 | 1,019 | ||
| Paul M. Spring | UAMS | 18 | 1,263 | ||
| Sayem Miah | UAMS | 15 | 539 | Faculty | |
| Bindu Subhadra | Arkansas Tech University | 14 | 785 | Faculty | |
| Shariq Ali | UA Little Rock | 14 | 1,271 | ||
| Mekonnen Lemma Dechassa | NCTR | 14 | 1,831 | ||
| Amit Kumar Tiwari | UAMS | 12 | 828 | High Impact | |
| Daniel T. Sloper | NCTR | 12 | 458 | ||
| Bridgett Knox | NCTR | 12 | 419 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 National Institutes of Health 2,099
- 2 National Cancer Institute 1,750
- 3 Harvard University 1,325
- 4 University of Washington 1,293
- 5 University of California, San Francisco 1,292
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Drug Transport And Resistance Mechanisms.